Inhibrx Biosciences Inc's total assets for Q3 2025 were $177.47M, a decrease of -16.33% from the previous quarter. INBX total liabilities were $140.64M for the fiscal quarter, a -2.03% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.